Metraipolis › archive › dc_4342f2dca435

Efficacy and safety of hetrombopag in the treatment of chemotherapy-related thrombocytopenia in solid tumors: a retrospective study — Europe PMC PMID:41229495

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41229495
DOI: 10.3389/fonc.2025.1670029
License (as archived): solo-consultazione
Archived: 2026-11-09T00:06:04.649Z
SHA-256 of the archived text: 3628d07f662fff24e7d94adc30522ada165630dca54355bfc791c576b88ad5de
Stable URL of this page: https://metraipolis.com/documento/dc_4342f2dca435

How to cite

Efficacy and safety of hetrombopag in the treatment of chemotherapy-related thrombocytopenia in solid tumors: a retrospective study — Europe PMC PMID:41229495 — Europe PMC (en), https://europepmc.org/article/MED/41229495 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4342f2dca435 (Metraipolis archive dc_4342f2dca435, sha256 3628d07f662fff24e7d94adc30522ada165630dca54355bfc791c576b88ad5de)

BibTeX

@misc{dc4342f2dca435,
  title = {Efficacy and safety of hetrombopag in the treatment of chemotherapy-related thrombocytopenia in solid tumors: a retrospective study — Europe PMC PMID:41229495},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41229495},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4342f2dca435; sha256 3628d07f662fff24e7d94adc30522ada165630dca54355bfc791c576b88ad5de},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41229495. Agents can read the archived copy with the MCP tool read_document.